Clinical trial
ALTROPANE® SPECT Imaging in Patients With Parkinson Disease
NCT00397228 · Molecular NeuroImaging, Other · Completed
Key facts
| NCT number | NCT00397228 |
|---|---|
| Title | ALTROPANE® SPECT Imaging in Patients With Parkinson Disease |
| Official title | Optimizing the Performance of ALTROPANE® SPECT Imaging in Patients With Parkinson Disease |
| Lead sponsor | Molecular NeuroImaging, Other |
| Collaborators | Institute for Neurodegenerative Disorders |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | ALTROPANE® |
| Enrollment | 27 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Nov 8, 2006 |
| Last update posted | Dec 16, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: